Queran Lin
Impact in
-
- Diabetes Treatment and Management
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Pharmacy top 10%
- Obesity and Health Practices
Papers in
- Health 2
-
- Ovarian cancer diagnosis and treatment 1
- Co-authors
- Pengpeng Ye (4 shared papers)Heqing Huang (2 shared papers)Markus Peter Schlaich (1 shared paper)Albertino Antonio Moura Damasceno (1 shared paper)George S. Stergiou (1 shared paper)Aletta Elisabeth Schutte (1 shared paper)Suzie Cro (1 shared paper)Michael A. Weber (1 shared paper)
- Journals
- The Lancet (6 papers)The Lancet Regional Health - Western Pacific (2 papers)Frontiers in Medicine (1 paper)JAMA (1 paper)The Lancet Oncology (1 paper)
- Partner nations
- ChinaUnited KingdomHong Kong
In The Last Decade
Queran Lin
25 papers receiving 1.1k citations
Queran Lin's Hit Papers
Peers
Comparison fields: 5 of 107
- Endocrinology, Diabetes and Metabolism 74
- Pharmacy 19
- Physiology 84
- Public Health, Environmental and Occupational Health 80
- Nephrology 18
Countries citing papers authored by Queran Lin
This map shows the geographic impact of Queran Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Queran Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Queran Lin more than expected).
Fields of papers citing papers by Queran Lin
This network shows the impact of papers produced by Queran Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Queran Lin. The network helps show where Queran Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Queran Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2025 | 428 |
| 2 | Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2025 | 177 |
| 3 | Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 Hit paper breakdown → | 2025 | 170 |
| 4 | Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 Hit paper breakdown → | 2025 | 128 |
| 5 | Global, regional, and national burden of asthma and atopic dermatitis, 1990–2021, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021 Hit paper breakdown → | 2025 | 76 |
| 6 | Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950–2023: a demographic analysis for the Global Burden of Disease Study 2023 Hit paper breakdown → | 2025 | 52 |
| 7 | Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023 with forecasts to 2030: a systematic analysis for the Global Burden of Disease Study 2023 Hit paper breakdown → | 2025 | 35 |
| 8 | 2022 | 32 | |
| 9 | Hormonal regulation of oocyte development and maturation of amphioxus. | 1994 | 7 |
| 10 | 2024 | 6 | |
| 11 | 2025 | 5 | |
| 12 | 2025 | 5 | |
| 13 | 2025 | 4 | |
| 14 | 2000 | 4 | |
| 15 | 2024 | 3 | |
| 16 | 2000 | 3 | |
| 17 | 2017 | 2 | |
| 18 | 2025 | 2 | |
| 19 | 2026 | 2 | |
| 20 | 2025 | 1 |
About Queran Lin
Queran Lin is a scholar working on Health, Reproductive Medicine, Epidemiology, Cancer Research and Immunology, having authored 28 papers that have together received 1.1k indexed citations. Recurring topics across this work include Acute Ischemic Stroke Management (2 papers), Cancer Genomics and Diagnostics (1 paper), Ovarian cancer diagnosis and treatment (1 paper), Chronic Kidney Disease and Diabetes (1 paper), Electrocatalysts for Energy Conversion (1 paper), Iron Metabolism and Disorders (1 paper), Dementia and Cognitive Impairment Research (1 paper) and Cancer-related molecular mechanisms research (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (74 citations), Pharmacy (19 citations), Physiology (84 citations), Public Health, Environmental and Occupational Health (80 citations) and Nephrology (18 citations). Queran Lin has collaborated with scholars based in China, United Kingdom and Hong Kong. Frequent co-authors include Pengpeng Ye, Heqing Huang, Markus Peter Schlaich, Albertino Antonio Moura Damasceno, George S. Stergiou, Aletta Elisabeth Schutte, Suzie Cro, Michael A. Weber, Thomas E Beaney and Neil R Poulter. Their work appears in journals such as The Lancet, The Lancet Regional Health - Western Pacific, Frontiers in Medicine, JAMA and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.